Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy

Urothelial bladder cancer (UBC) is one of the most common lethal cancer worldwide and the 5-year survival rate has not improved significantly with current treatment protocols during the last decade. Intravesical immunotherapy with Bacillus Calmette-Guérin is currently the standard care for non-muscl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Wen, Fu, Dian, Xu, Feng, Zhang, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833720/
https://www.ncbi.nlm.nih.gov/pubmed/29358573
http://dx.doi.org/10.1038/s41389-017-0013-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833720/
https://www.ncbi.nlm.nih.gov/pubmed/29358573
http://dx.doi.org/10.1038/s41389-017-0013-7

Ejemplares similares